| | Control group (n = 130) | GDFT group (n = 130) |
p
|
|---|
Age (years) | 72 (60–76) | 71 (62–75) | 0.643 |
Sex (w/m) | 86/44 | 81/49 | 0.440 |
Body height (cm) | 166 (160–171) | 168 (163–175) | 0.155 |
Body weight (kg) | 76 (65–85) | 79 (64–90) | 0.177 |
BMI kg/m2
| 27.36 (24.69–30.06) | 27.77 (23.80–32.11) | 0.658 |
CCS | 3 (2–5) | 3 (2–4) | 0.249 |
ASA score | 2 (2–3) | 2 (2–3) | 0.730 |
P-POSSUM score | 27.00 (23.00–31.00) | 29.00 (24.00–33.00) | 0.102 |
- Parameters are shown as median and (25th percentile–75th percentile). CCS: The Charlson Comorbidity Score includes age, previous myocardial infarction or congestive heart failure, peripheral vascular disease, cerebrovascular disease, existing dementia, COPD, connective tissue disease, peptic ulcer disease, diabetes mellitus, moderate to severe chronic kidney disease, hemiplegia, leukaemia, malignant lymphoma, solid tumour, liver disease, and AIDS. Different points were distributed for the pre-existing diseases, and so, the survival rate during the first 2 years can be calculated
